Conditions: Metastatic Breast Cancer
Keywords: Endocrine Therapy, Taxane, MONARCH 1
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 132
Healthy volunteers: no

Brief summary:
The main purpose of this study is to evaluate whether the study drug known as abemaciclib is effective in treating participants with breast cancer who have already tried other drug treatments.

Detailed description:

Arms:
arm 1: 200 milligrams (mg) abemaciclib given orally once every 12 hours for 28 days (1 cycle). Participants may continue to receive treatment until discontinuation criteria are met.

Interventions: intervention 1: Abemaciclib
Intervention descriptions: intervention 1: Administered orally

Protocol document: